Clinical Trials Directory

Trials / Unknown

UnknownNCT02238093

Cardiorenal Syndrome in End-Stage Kidney Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
270 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality. The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-09-12
Last updated
2014-09-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02238093. Inclusion in this directory is not an endorsement.

Cardiorenal Syndrome in End-Stage Kidney Disease (NCT02238093) · Clinical Trials Directory